Patent Assignment
Reel/Frame 061494/0528
Merger
Recorded: 2022-10-21
Pages: 5
Assignor
COMET THERAPEUTICS, INC.
Executed: 2022-07-07
Assignee
VECTIVBIO COMET AG
AESCHENVORSTADT 36, BASEL, 4051, SWITZERLAND
Covered Property
(1)
Phosphopantetheine Compounds Alone or in Combination with Hmg-Coa Reductase Inhibitors for Lowering Serum Cholesterol and Serum Triglicerides
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 24, 2017
From: ACIES BIO D.O.O.
To: TM3 THERAPEUTICS B.V.
Reel/Frame 044583/0321 →
Assignment of Assignor's Interest
Apr 8, 2019
From: KOSEC, GREGOR; FUJS, STEFAN; PETKOVIC, HRVOJE
To: ACIES BIO D.O.O.
Reel/Frame 048819/0304 →
Assignment of Assignor's Interest
Apr 8, 2019
From: SIBON, ODA CORNELIA MARIA; SRINIVASAN, BALAJI
To: RIJKSUNIVERSITEIT GRONINGEN; ACADEMISCH ZIEKENHUIS GRONINGEN
Reel/Frame 048819/0346 →
Change of Name
Jan 27, 2020
From: TM3 THERAPEUTICS B.V.
To: COMET THERAPEUTICS B.V.
Reel/Frame 051624/0646 →
Assignment of Assignor's Interest
Jan 27, 2020
From: COMET THERAPEUTICS B.V.
To: COMET THERAPEUTICS, INC.
Reel/Frame 051624/0654 →
Security Interest
Mar 29, 2022
From: COMET THERAPEUTICS, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 059420/0866 →
Release of Security Interest
Aug 24, 2023
From: KREOS CAPITAL VI (UK) LIMITED
To: VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC.
Reel/Frame 064702/0362 →